Transcatheter aortic valve replacement: when should we say no?

Open Heart · 2022 · PMC8734017 · PMID 34987074

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

3 Similarly, in high-risk operable patients (PARTNER Cohort A and CoreValve US Pivotal Trial), TAVR was associated with a highly significant and clinically meaningful improvement in the KCCQ-OS Score (increase of 20–30 points) at 1 month, 6 months and 1 year compared with the baseline, 4 5 with a more rapid improvement in TAVR arm compared with surgery (1-month scores greater after TAVR).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.